Jorge R. Oksenberg

Jorge R. Oksenberg's AcademicInfluence.com Rankings

Jorge R. Oksenberg

Biology

#10238

World Rank

#13546

Historical Rank

Immunology

#639

World Rank

#660

Historical Rank

Genetics

#1068

World Rank

#1167

Historical Rank

Neuroscience

#1572

World Rank

#1623

Historical Rank

biology Degrees

Download Badge

Biology

Jorge R. Oksenberg's Degrees

PhD Immunology University of Buenos Aires

Why Is Jorge R. Oksenberg Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jorge R. Oksenberg's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis (2011) (2511)
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis (2002) (1710)
Risk alleles for multiple sclerosis identified by a genomewide study. (2007) (1380)
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis (2013) (1170)
Common variants on chromosome 6p22.1 are associated with schizophrenia (2009) (1146)
Cytokine gene polymorphism in human disease: on-line databases (1999) (898)
The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease (2001) (805)
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci (2009) (799)
The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration (2006) (760)
A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex (1996) (681)
Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis (2007) (660)
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility (2019) (589)
Methods for high-density admixture mapping of disease genes. (2004) (477)
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis (2010) (466)
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (2009) (464)
Genome-wide patterns of population structure and admixture in West Africans and African Americans (2009) (426)
Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis (1993) (410)
Limited heterogeneity of rearranged T-cell receptor Vα transcripts in brains of multiple sclerosis patients (1990) (407)
Pathway and network-based analysis of genome-wide association studies in multiple sclerosis (2009) (400)
The genetics of multiple sclerosis: SNPs to pathways to pathogenesis (2008) (340)
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. (2004) (334)
Vitamin D status is associated with relapse rate in pediatric‐onset multiple sclerosis (2010) (321)
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. (2006) (310)
A high-density screen for linkage in multiple sclerosis. (2005) (308)
Long‐term evolution of multiple sclerosis disability in the treatment era (2016) (308)
Interferon beta‐1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis (1996) (307)
B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. (1999) (305)
HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. (2003) (299)
Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. (1998) (290)
Cytokine gene polymorphism in human disease: on-line databases, Supplement 1 (2001) (282)
The Population Reference Sample, POPRES: a resource for population, disease, and pharmacological genetics research. (2008) (271)
A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility (2005) (271)
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis (2004) (263)
Class II HLA interactions modulate genetic risk for multiple sclerosis (2015) (262)
The immunogenetics of multiple sclerosis: A comprehensive review. (2015) (257)
Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases (2009) (256)
Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. (2002) (255)
Transancestral mapping and genetic load in systemic lupus erythematosus (2017) (253)
Suppressive vaccination with DNA encoding a variable region gene of the T–cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity (1996) (253)
Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects (2013) (252)
High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis (2014) (250)
Cytokine gene polymorphism in human disease: on-line databases, Supplement 2 (2002) (247)
IL2RA Genetic Heterogeneity in Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production (2009) (244)
Silent progression in disease activity–free relapsing multiple sclerosis (2019) (216)
The role of the CD58 locus in multiple sclerosis (2009) (200)
Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study (2006) (198)
Multiple sclerosis genetics (2018) (184)
A second major histocompatibility complex susceptibility locus for multiple sclerosis (2007) (181)
Multiple sclerosis: Prospects and promise (2013) (179)
Predominant expression of T cell receptor V alpha 7 in tumor-infiltrating lymphocytes of uveal melanoma. (1990) (178)
Transcription-Based Prediction of Response to IFNβ Using Supervised Computational Methods (2004) (175)
Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come. (2010) (172)
Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation (2011) (165)
Peroxisome proliferator–activated receptor (PPAR)α expression in T cells mediates gender differences in development of T cell–mediated autoimmunity (2007) (162)
Genetic basis for clinical expression in multiple sclerosis. (2002) (159)
The expanding genetic overlap between multiple sclerosis and type I diabetes (2009) (157)
Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis. (2008) (156)
Transcriptional Analysis of Multiple Sclerosis Brain Lesions Reveals a Complex Pattern of Cytokine Expression1 (2000) (155)
HLA Diversity in the 1000 Genomes Dataset (2014) (151)
Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls. (2013) (149)
The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years. (2017) (147)
Multiple sclerosis: Genomic rewards (2001) (144)
Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. (2009) (143)
T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis. (1989) (140)
Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. (2009) (139)
Common viruses associated with lower pediatric multiple sclerosis risk (2011) (138)
Multiple sclerosis genetics: leaving no stone unturned (2005) (134)
Multiple sclerosis genetics—is the glass half full, or half empty? (2010) (134)
CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis (2000) (133)
Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection. (1993) (128)
Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. (2002) (123)
Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor (2009) (123)
The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. (2005) (121)
Response to Comment on "The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease" (2003) (117)
Perivascular T Cells Express the Pro‐Inflammatory Chemokine RANTES mRNA in Multiple Sclerosis Lesions (1997) (115)
Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions. (2006) (115)
Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing. (2016) (114)
Conferral of Enhanced Natural Killer Cell Function by KIR3DS1 in Early Human Immunodeficiency Virus Type 1 Infection (2008) (114)
The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility (2017) (113)
Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis (2019) (112)
Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. (2010) (111)
Multiple sclerosis susceptibility alleles in African Americans (2009) (109)
Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci (2009) (107)
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event (2008) (105)
Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years. (2019) (105)
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2018) (98)
A meta-analysis of genomic screens in multiple sclerosis. The Transatlantic Multiple Sclerosis Genetics Cooperative. (2001) (96)
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. (2011) (95)
Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA. (2009) (94)
Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. (1997) (93)
APOE epsilon variation in multiple sclerosis susceptibility and disease severity (2006) (89)
Multiple susceptibility loci for multiple sclerosis. (2002) (89)
Enhancing linkage analysis of complex disorders: an evaluation of high-density genotyping. (2004) (86)
Assessing the accuracy of observer-reported ancestry in a biorepository linked to electronic medical records (2010) (84)
Aggregation of multiple sclerosis genetic risk variants in multiple and single case families (2011) (84)
The Immunobiology of Multiple Sclerosis: An Autoimmune Disease of the Central Nervous System (1999) (84)
Uncoupling the Roles of HLA-DRB1 and HLA-DRB5 Genes in Multiple Sclerosis1 (2008) (84)
Analysis of the T cell repertoire using the PCR and specific oligonucleotide primers. (1992) (83)
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study (2022) (83)
γδ T cell receptor repertoire in brain lesions of patients with multiple sclerosis (1993) (82)
Familial effects on the clinical course of multiple sclerosis (2006) (82)
Fine-mapping, trans-ancestral, and genomic analyses identify causal variants, cells, genes, and drug targets for type 1 diabetes (2020) (79)
Characterization of T‐Cell Receptor αβ Repertoire in Synovial Tissue from Different Temporal Phases of Rheumatoid Arthritis (1992) (78)
Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis (2003) (74)
Genetic factors in multiple sclerosis. (1993) (74)
IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci (2010) (72)
Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls. (2013) (72)
The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-β (2002) (71)
Vitamin D in African Americans with multiple sclerosis (2011) (70)
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility (2010) (70)
PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients (2001) (69)
MIF and D-DT are potential disease severity modifiers in male MS subjects (2017) (68)
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies (2016) (68)
Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. (1993) (67)
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data (2011) (66)
T-cell receptor V-gene usage in synovial fluid lymphocytes of patients with chronic arthritis. (1993) (65)
The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse (2007) (64)
Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis (2004) (64)
Synergy or Independence? Deciphering the Interaction of HLA Class I and NK Cell KIR Alleles in Early HIV-1 Disease Progression (2007) (63)
A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis (2011) (63)
HLA-DP beta and susceptibility to multiple sclerosis: an analysis of caucasoid and Japanese patient populations. (1990) (61)
An ImmunoChip study of multiple sclerosis risk in African Americans. (2015) (60)
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis. (2016) (59)
A second-generation genomic screen for multiple sclerosis. (2004) (59)
Decoding multiple sclerosis: an update on genomics and future directions (2013) (59)
Genetics of Demyelinating Diseases (1996) (58)
Osteopontin polymorphisms and disease course in multiple sclerosis (2003) (57)
Analysis of T Cell Receptor Repertoire of Muscle-infiltrating T Lymphocytes in Polymyositis (1993) (57)
A Major Histocompatibility Class I Locus Contributes to Multiple Sclerosis Susceptibility Independently from HLA-DRB1*15:01 (2010) (56)
Maternal-paternal histocompatibility: lack of association with habitual abortions. (1984) (56)
The complex genetic aetiology of multiple sclerosis. (2000) (55)
The HLA locus and multiple sclerosis in Sicily (2005) (55)
Diversity of T-cell antigen receptor variable genes used by mycosis fungoides cells. (1992) (55)
A genome-wide association study of brain lesion distribution in multiple sclerosis. (2013) (55)
Genetic risk variants in African Americans with multiple sclerosis (2013) (54)
Multifactor dimensionality reduction reveals gene–gene interactions associated with multiple sclerosis susceptibility in African Americans (2006) (54)
Mitochondrial DNA sequence variation in multiple sclerosis (2015) (53)
Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15. (2006) (53)
Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchus. (1997) (51)
CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis. (2010) (50)
Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS (2000) (49)
Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis (2009) (48)
Identification of MS-specific serum miRNAs in an international multicenter study (2018) (47)
Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis. (2009) (47)
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis (2014) (47)
The Antigen t Cell Receptor: Selected Protocols and Applications (1997) (47)
Antigen-presenting cells in human decidual tissue. (1986) (46)
Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score (2019) (45)
KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19 (2022) (45)
Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity (2013) (45)
No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis (2013) (43)
IL 12 A , MPHOSPH 9 / CDK 2 AP 1 and RGS 1 are novel multiple sclerosis susceptibility loci (2010) (41)
A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson’s disease (2019) (41)
Genome-Wide Network Analysis Reveals the Global Properties of IFN-β Immediate Transcriptional Effects in Humans12 (2007) (41)
Modular Transcriptional Activity Characterizes the Initiation and Progression of Autoimmune Encephalomyelitis1 (2005) (41)
Mapping gene activity in complex disorders: Integration of expression and genomic scans for multiple sclerosis (2005) (40)
Genetic aspects of multiple sclerosis. (1999) (40)
In vitro suppression of murine blastocysts growth by sera from women with reproductive disorders. (1986) (40)
CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. (2000) (39)
Clinical characteristics of responders to interferon therapy for relapsing MS (2004) (39)
Refining the association of MHC with multiple sclerosis in African Americans. (2010) (38)
Variation within DNA repair pathway genes and risk of multiple sclerosis. (2010) (38)
Complex gene–gene interactions in multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes (2006) (38)
The role of TNFα and lymphotoxin in demyelinating disease (1999) (37)
Polymorphic markers of human T-cell receptor alpha and beta genes. Family studies and comparison of frequencies in healthy individuals and patients with multiple sclerosis and myasthenia gravis. (1988) (36)
A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis (2019) (36)
Longitudinal system-based analysis of transcriptional responses to type I interferons. (2009) (36)
Evidence of novel fine-scale structural variation at autism spectrum disorder candidate loci (2012) (36)
In depth comparison of an individual’s DNA and its lymphoblastoid cell line using whole genome sequencing (2012) (35)
Association of susceptibility to multiple sclerosis with TCR genes. (1992) (35)
Linkage and association analysis of chromosome 19q13 in multiple sclerosis (2001) (34)
Human leukocyte antigens (HLA) class I and class II on sperm cells studied at the serological, cellular, and genomic levels. (1987) (34)
Copy number variation in African Americans (2009) (34)
IFN‐&ggr; orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways (2017) (34)
A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility (2010) (33)
Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis (2018) (33)
Genetic determinants of risk and progression in multiple sclerosis. (2015) (33)
SNPs in Multi-Species Conserved Sequences (MCS) as useful markers in association studies: a practical approach (2007) (33)
Next-generation sequencing reveals new information about HLA allele and haplotype diversity in a large European American population. (2019) (33)
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2018) (33)
The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. (2007) (32)
Genetic associations with brain cortical thickness in multiple sclerosis (2015) (31)
Peroxisome proliferator–activated receptor (PPAR)α expression in T cells mediates gender differences in development of T cell–mediated autoimmunity (2007) (31)
Genetic burden in multiple sclerosis families (2013) (31)
Power estimation for non-standardized multisite studies (2016) (31)
Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis (2013) (31)
Mixed lymphocyte reactivity nonresponsiveness in couples with multiple spontaneous abortions. (1983) (30)
HLA-D locus in Israel. Characterization of 14 local HTC's and a population study. (2008) (30)
ApoE alleles, depression and positive affect in multiple sclerosis (2009) (29)
Multiple sclerosis genetics 2010. (2011) (29)
Sequence variation in the transforming growth factor-β1 (TGFB1) gene and multiple sclerosis susceptibility (2001) (29)
Telomere Length Is Associated with Disability Progression in Multiple Sclerosis (2019) (28)
New insights into the immunogenetics of multiple sclerosis (1997) (28)
Genetics of multiple sclerosis. (2005) (28)
Multiple sclerosis: a polygenic disease involving epistatic interactions, germline rearrangements and environmental effects (1997) (28)
APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection. (2011) (28)
Heterogeneity at the HLA-DRB 1 locus and risk for multiple sclerosis (2006) (27)
Cellular immunity in human milk. (1985) (27)
HLA-D typing in multiple sclerosis: Israelis tested with European homozygous typing cells. (1982) (26)
Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group. (2000) (26)
Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis (2010) (26)
Gamma delta T cell receptor repertoire in brain lesions of patients with multiple sclerosis. (1993) (26)
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis. (2014) (26)
Evolution of the CCR5 Delta32 mutation based on haplotype variation in Jewish and Northern European population samples. (2001) (25)
SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients (2011) (25)
Analysis of antibody gene rearrangement, usage, and specificity in chronic focal encephalitis (2002) (25)
Evaluating the genomic and sequence integrity of human ES cell lines; comparison to normal genomes. (2012) (25)
Linkage analysis of candidate myelin genes in familial multiple sclerosis (1999) (25)
Multiple Sclerosis Overview (2010) (24)
Genetic overlap between autoimmune diseases and non‐Hodgkin lymphoma subtypes (2019) (24)
Analysis of the T-cell receptor repertoire in human atherosclerosis. (1997) (24)
The role of the MHC and T-cell receptor in susceptibility to multiple sclerosis. (1990) (24)
Multiple sclerosis and oligodendroglioma (2001) (24)
Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA) (2002) (24)
A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis (2010) (24)
Gene expression analysis reveals altered brain transcription of glutamate receptors and inflammatory genes in a patient with chronic focal (Rasmussen's) encephalitis (2002) (24)
Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients (1991) (23)
Correction: Synergy or Independence? Deciphering the Interaction of HLA Class I and NK Cell KIR Alleles in Early HIV-1 Disease Progression (2007) (23)
The killer immunoglobulin-like receptor KIR3DL1 combination with HLA-Bw4 is protective against multiple sclerosis in African Americans (2016) (23)
Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course (2018) (22)
Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study (2004) (22)
Increased incidence of certain TCR and HLA genes associated with myasthenia gravis in Italians. (1990) (22)
Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis (2021) (22)
Household paired design reduces variance and increases power in multi-city gut microbiome study in multiple sclerosis (2020) (22)
Gender-Associated Differences of Perforin Polymorphisms in the Susceptibility to Multiple Sclerosis (2010) (22)
Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course (2022) (21)
Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones. (1992) (21)
Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6 (2013) (21)
Ovarian aging is associated with gray matter volume and disability in women with MS (2018) (20)
Pharmacogenomic study in patients with multiple sclerosis (2015) (20)
Analysis of IL4R haplotypes in predisposition to multiple sclerosis (2004) (20)
Genetic variation in the odorant receptors family 13 and the mhc loci influence mate selection in a multiple sclerosis dataset (2010) (20)
Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis (2016) (20)
Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel (2010) (20)
Differential impact of the CD45 juxtamembrane wedge on central and peripheral T cell receptor responses (2009) (20)
Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals. (2010) (19)
HLA-D clusters associated with DR2 and the definition of HLA-D"AZH": a new DR2 related HLA-D specificity in Israel. (2008) (19)
Evidence for the genetic role of human leukocyte antigens in low frequency DRBI*1501 multiple sclerosis patients in Israel (1999) (19)
Detection of identity by descent using next-generation whole genome sequencing data (2012) (19)
Early editorial manuscript screening versus obligate peer review: A randomized trial (2007) (19)
The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States (2020) (19)
HTLV‐I sequences are not detected in peripheral blood genomic DNA or in brain cDNA of multiple sclerosis patients (1990) (19)
Increased Transcriptional Activity of Milk-Related Genes following the Active Phase of Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis1 (2007) (19)
The epigenetics of multiple sclerosis: clues to etiology and a rationale for immune therapy. (1994) (19)
A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome. (2015) (18)
The role of TNFalpha and lymphotoxin in demyelinating disease. (1999) (18)
IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis (2011) (18)
MHC-restricted recognition of immunogenic T cell epitopes of pertussis toxin reveals determinants in man distinct from the ADP-ribosylase active site (1988) (17)
Native ancestry is associated with optic neuritis and age of onset in hispanics with multiple sclerosis (2018) (17)
Examination of seven candidate regions for multiple sclerosis: strong evidence of linkage to chromosome 1q44 (2006) (17)
Antigen presenting cells in human decidual tissue: III. Role of accessory cells in the activation of suppressor cells. (1988) (17)
Influence of HLA-DR2, HLA-DPw4, and T cell receptor alpha chain genes on the susceptibility to multiple sclerosis. (1992) (17)
Multiple sclerosis pharmacogenomics (2010) (17)
Multiple sclerosis genetics. (2018) (16)
The polymerase chain reaction for detection of T-cell antigen receptor expression (1992) (16)
Characterization of T-cell receptor alpha beta repertoire in synovial tissue from different temporal phases of rheumatoid arthritis. (1992) (15)
Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 class II haplotypes using next-generation sequencing in European-Americans with multiple sclerosis (2019) (15)
Fighting decision fatigue (2012) (15)
The polymerase chain reaction for detection of T-cell antigen receptor expression. (1992) (15)
Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17th International HLA and Immunogenetics Workshop. (2018) (14)
Cyclic adenosine 3',5'-monophosphate metabolism in activated T-cell clones. (1989) (14)
Neuroinformatics in clinical practice: are computers going to help neurological patients and their physicians? (2006) (14)
Copy number variation in pediatric multiple sclerosis (2013) (13)
Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients (2018) (13)
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2020) (13)
HLA-DR, D recombination in a kidney transplant recipient. (1982) (13)
MS in self-identified Hispanic/Latino individuals living in the US (2017) (13)
Killer Cell Immunoglobulin-like Receptor Variants Are Associated with Protection from Symptoms Associated with More Severe Course in Parkinson Disease (2020) (13)
T‐Cell Receptor Gene Usage of Acetylcholine Receptor‐specific T‐Helper Cells (1993) (12)
New insights into the genetics of multiple sclerosis. (2002) (12)
Limited allelic polymorphism in the human interleukin-3 gene. (1998) (12)
Multiple T and B cell epitopes in the S1 subunit ("A"-monomer) of the pertussis toxin molecule. (1989) (11)
Immunogenetics and heterogeneity in multiple sclerosis (1996) (11)
Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy (2005) (11)
High Resolution HLA Analysis Reveals Independent Class I Haplotypes and Amino-Acid Motifs Protective for Multiple Sclerosis (2017) (11)
Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis (2020) (11)
Allelic association of sequence variants in the herpes virus entry mediator-B gene (PVRL2) with the severity of multiple sclerosis (2006) (11)
New allelic polymorphisms in TAP genes (2004) (11)
High-Resolution Characterization of KIR Genes in a Large North American Cohort Reveals Novel Details of Structural and Sequence Diversity (2021) (11)
Histocompatibility antigens, mixed lymphocyte reactivity and severe preeclampsia in Israel. (1983) (11)
Antigen presenting cells in human decidual tissue. II: Accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes. (1987) (11)
Two genetic variants explain the association of European ancestry with multiple sclerosis risk in African-Americans (2020) (10)
Genetic contribution to multiple sclerosis risk among Ashkenazi Jews (2015) (10)
HLA-linked SB antigens in Israel (1984) (10)
HLA-D "BG" in Israel. A Japanese related allele population and family study. (2008) (10)
Longitudinal analysis of T-cell receptor gene use by CD8(+) T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapy. (2001) (10)
Fine-mapping the genetic basis of CRP regulation in African Americans: a Bayesian approach (2008) (9)
Follow-up examination of linkage and association to chromosome 1q43 in multiple sclerosis (2009) (9)
Genomics and new targets for multiple sclerosis. (2005) (9)
Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans. (2022) (9)
T-Cell Receptor Repertoire Vβ in Alopecia Areata (1995) (8)
Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosis (2008) (8)
Immune cell-specific transcriptional profiling highlights distinct molecular pathways controlled by Tob1 upon experimental autoimmune encephalomyelitis (2016) (8)
Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation. (2019) (8)
Decoding Multiple Sclerosis (2011) (8)
Differential display analysis of murine encephalitogenic mRNA. (1998) (8)
Iconographies supplémentaires de l'article : IFN-? orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways (2016) (8)
United Europeans for development of pharmacogenomics in multiple sclerosis network. (2009) (8)
Specific hypomethylation programs underpin B cell activation in early multiple sclerosis (2021) (7)
Histoincompatibility in couples with unexplained infertility. (1985) (7)
Chromosome 17q22–q24 and multiple sclerosis genetic susceptibility (1999) (7)
A Fast Multivariate Feature-Selection/Classification Approach for Prediction of Therapy Response in Multiple Sclerosis (2006) (6)
Chronic inflammatory diseases of the nervous system. (1998) (6)
Genetic studies of multiple sclerosis and neuromyelitis optica: Current status in European, African American and Asian populations (2014) (6)
Oligodendrocyte-specific Argonaute profiling identifies microRNAs associated with experimental autoimmune encephalomyelitis (2020) (6)
Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosis (2008) (6)
Longitudinal analysis of B cell repertoire and antibody gene rearrangements during early HIV infection (2005) (6)
Restricted T-cell receptor usage in spinal cord and brain of patients with amyotrophic lateral sclerosis (1991) (5)
Two new HLA-B alleles, B*4422 and B*4704, identified in a study of families with autoimmunity. (2002) (5)
The Polymerase Chain Reaction and the Analysis of the t Cell Receptor Repertoire (1992) (5)
New approaches to the therapy of demyelinating disease (1991) (5)
Quantitative longitudinal analysis of T cell receptor repertoire expression in HIV-infected patients on antiretroviral and interleukin-2 therapy. (2007) (5)
Chapter 85 – Multiple Sclerosis (2015) (4)
Genetic polymorphism at codon 129 of the prion protein gene is not associated with multiple sclerosis. (2009) (4)
Multiple sclerosis: two decades of progress (2022) (4)
Biological concepts of multiple sclerosis pathogenesis and relationship to treatment (2007) (4)
Neurogenetics in the Annals: Dealing with complexity (2008) (4)
Transcriptional expression patterns triggered by chemically distinct neuroprotective molecules (2012) (4)
Chromosome 7q21–22 and multiple sclerosis (2004) (4)
Pathogenesis of Multiple Sclerosis: Relationship to Therapeutic Strategies (1996) (4)
Serum antibodies to phosphatidylcholine in MS (2020) (4)
F.27. Meta-analysis of Genome Scans and Replication Identify CD6, ICSBP1, and TNFRSF1A as Novel Multiple Sclerosis Susceptibility Loci (2009) (3)
Genetics of Multifactorial Disorders (2006) (3)
Status report: The Annals in 2010 (2010) (3)
Author Correction: A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis (2019) (3)
MHC*IMP – Imputation of Alleles for Genes in the Major Histocompatibility Complex (2020) (3)
Correction: Peroxisome proliferator–activated receptor (PPAR)α expression in T cells mediates gender differences in development of T cell–mediated autoimmunity (2018) (3)
Analysis of T Cell Receptor Repertoire of Muscle-infiltrating T Lymphocytes in Polymyositis Restricted (2013) (2)
Meta-Analysis of Hodgkin Lymphoma and Asthma Genome-Wide Association Scans reveals common variants in GATA3 (2014) (2)
Multiple sclerosis: From immunogenetics to immunotherapy (1993) (2)
T-cell receptor repertoire V beta in alopecia areata. (1995) (2)
A status report on the Annals (2008) (2)
No HLA compatibility in multiple spontaneous abortions (1983) (2)
Accelerated Cord Atrophy Precedes Conversion to Secondary Progressive Disease in Relapsing Multiple Sclerosis (2019) (2)
Selective targeting of the immune response in autoimmune demyelination. (1994) (2)
Genetic susceptibility to multiple sclerosis in African Americans (2021) (2)
Correction: High resolution HLA analysis reveals independent class I haplotypes and amino-acid motifs protective for multiple sclerosis (2018) (2)
Transforming growth factor (TGF)-β1 modifies Alzheimer's-type pathology in a transgenic mice and humans (2000) (2)
Large-Scale Imputation of KIR Copy Number and HLA Alleles in North American and European Psoriasis Case-Control Cohorts Reveals Association of Inhibitory KIR2DL2 With Psoriasis (2021) (2)
Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations (2021) (2)
High Resolution Haplotype Analyses of Classical HLA Genes in Families With Multiple Sclerosis Highlights the Role of HLA-DP Alleles in Disease Susceptibility (2021) (2)
Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosis (2022) (2)
In depth comparison of an individual’s DNA and its lymphoblastoid cell line using whole genome sequencing (2012) (1)
T cell receptor usage in brains of multiple sclerosis patients. Correlation with HLA class II molecular phenotype (1991) (1)
Reply to “Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS” (2022) (1)
Epigenetic control of ataxin‐1 in multiple sclerosis (2022) (1)
TopoDB: a novel multifunctional management system for laboratory animal colonies (2020) (1)
A Genetic Model Predicts the Response to Glatiramer Acetate in Two Different Cohorts (P05.129) (2012) (1)
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies (2022) (1)
Combined influence of HLA DR2, DRw4 and T cell receptor genes on the susceptibility of multiple sclerosis (1991) (1)
T-CELL RECEPTOR REPERTOIRE VBETA IN ALOPECIA AREATA (1995) (1)
Whole genome sequences of 2 octogenarians with sustained cognitive abilities (2015) (1)
Mapping the human genome with newfound precision (2010) (1)
Review article Multiple sclerosis: Genomic rewards (2001) (1)
Chapter 4 – Genetics of Multiple Sclerosis (2016) (1)
Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course (2018) (1)
P088 Haplotype analyses of classical HLA genes from families (2017) (1)
Human KIR+CD8+ T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19 (2021) (1)
A Genetic Model To Predict Response to Glatiramer Acetate Developed from a Genome Wide Association Study (GWAS) (IN3-2.003) (2012) (1)
A splice acceptor variant in HLA‐DRA affects the conformation and cellular localization of the class II DR alpha‐chain (2020) (1)
Conferral of Enhanced Natural Killer Cell Function by KIR3DS1 in Early Human Immunodeﬁciency Virus Type 1 Infection (cid:1) (2008) (1)
APOBEC3H Haplotypes and HIV-1 Pro-Viral vif DNA Sequence Diversity in Early Untreated HIV-1 Infection (2011) (1)
T cell receptor variability in myasthenia gravis (1991) (1)
Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population (2022) (0)
T-cell infiltration in the muscles of boys with Duchenne muscular dystrophy pre and post transfer of normal myoblasts (1991) (0)
Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients (2018) (0)
Cytokine Expression Brain Lesions Reveals a Complex Pattern of Transcriptional Analysis of Multiple Sclerosis (2000) (0)
T cell receptor tcr usage in brains of multiple sclerosis patients (1992) (0)
299 A High Density Association Study of the Extended Major Histocompatibility Locus in Ulcerative Colitis and Crohn's Disease (2008) (0)
OR.102. The CD58 Pathway is Implicated in MS Susceptibility (2008) (0)
High resolution HLA analysis reveals independent class I haplotypes and amino-acid motifs protective for multiple sclerosis (2018) (0)
Accelerated Worsening in Serum Neurofilament Light Chain Levels and Multiple Sclerosis Functional Composite in Women with MS after Menopause (S9.009) (2023) (0)
Imputation of KIR Genes in over 80,000 Samples Reveals Previously Unknown Associations with Psoriasis (2018) (0)
OR4 High resolution haplotype analyses of classical HLA genes in families with multiple sclerosis (2018) (0)
Compositions for use in a method tilbehandling of a human suffering from sclerosis afdissemineret (1991) (0)
Correction: High resolution HLA analysis reveals independent class I haplotypes and amino-acid motifs protective for multiple sclerosis (2018) (0)
[The HLA system and habitual spontaneous abortions]. (1986) (0)
456 Independent causal effect of psoriasis on multiple sclerosis identified by Mendelian randomization (2022) (0)
Detection of Vγ and V° transcripts in multiple sclerosis lesions (1991) (0)
Oligodendrocyte-specific Argonaute profiling identifies microRNAs associated with experimental autoimmune encephalomyelitis (2020) (0)
T-cell receptor V. and Ca alleles associated with multiple sclerosis and myasthenia gravis (0)
A short HLA-DRA isoform binds the HLA-DR2 heterodimer on the outer domain of the peptide-binding site. (2022) (0)
Clustering of autoimmune disease in families at high risk for multiple sclerosis? – Authors' reply (2007) (0)
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci | NOVA. The University of Newcastle's Digital Repository (2011) (0)
Thanks to Our Authors, Reviewers and Publisher (2011) (0)
Induction of T-suppressor cells by human decidual antigen presenting cells primed with fetal antigens (1988) (0)
F.33. The IMAGEN Consortium: A High-density SNP Map of the MHC in Lupus Identifies Multiple Independent Disease-associated Variants (2009) (0)
Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes (2023) (0)
F.24. Longitudinal System-based Analysis Uncovers Both General and Specific Transcriptional Responses to Type I Interferons (2009) (0)
Molecular analysis of TCR repertoire of T cell infiltrate in polymyiositis muscle: Evidence for restricted α/β rearrangement (1991) (0)
Multiple Sclerosis Therapeutics: The genetics of multiple sclerosis (2011) (0)
Table 1. [Risk Estimates for Multiple Sclerosis in First-Degree Relatives of a Proband]. (2010) (0)
The role of the CD[subscript 5]8 locus in multiple sclerosis (2009) (0)
A High Density Association Study of the Extended Major Histocompatibility Locus in Ulcerative Colitis (2007) (0)
Whole-Exome Sequencing in Multiplex Families Identifies Novel Rare Variants in Multiple Sclerosis (P05.137) (2013) (0)
Correction: Gender-Associated Differences of Perforin Polymorphisms in the Susceptibility to Multiple Sclerosis (2011) (0)
TCR repertoire in non-human primates: Diversity of T-cell response against MBP (1995) (0)
No evidence of linkage of multiple sclerosis to chromosome 17q22-24 in American and French multiplex families (1999) (0)
Compositions for use in a method for treating a patient suffering from multiple sclerosis People (1991) (0)
Large-scale imputation of killer cell immunoglobulin-like receptor copy number in psoriatic arthritis (2017) (0)
POLYMORPHISM IN MS. REPLY (1992) (0)
Pharmacogenomic analysis of immunotherapy in multiple sclerosis (2002) (0)
Detection of identity by descent using next-generation whole genome sequencing data (2012) (0)
The influence of HLA-C alleles on multiple sclerosis in African Americans (2003) (0)
Investigation of novel type 1 diabetes loci in multiple sclerosis (2009) (0)
Quo vadis? – peering into the future (2013) (0)
HLA-linked SB antigens in Israel. Population study, analysis of homozygous typing cells and generation of local SB reagents. (1984) (0)
Oral Presentations (2017) (0)
High density mapping of the MHC reveals a common role for HLA- DRB1*01:03 in IBD and heterozygous advantage in ulcerative colitis (2014) (0)
Sa.18. PPARα Mediates the Sexual Dimorphism in the Development of Th1-Mediated CNS Autoimmune Disease (2006) (0)
Genes, genomes and neurological disease (2006) (0)
Limited heterogeneity of rearranged T-cell receptor V α transcripts in brains of multiple sclerosis patients (1991) (0)
198-P: HLA immunogenetics of multiple sclerosis in Israeli arabs (2009) (0)
Genes in Multiple Sclerosis HLA-DRB 5 and HLA-DRB 1 Uncoupling the Roles of Barcellos and (2008) (0)
OR.22. Dissection of the Admixture Multiple Sclerosis Susceptibility Locus On Chromosome 1 in An African-American Population (2006) (0)
Re: GAMES issue. (2004) (0)
Shared Genetic Risk Factors for MS/Psoriasis suggest involvement of IL17 and JAK-STAT signaling. (2023) (0)
Have the Annals editors added value? (2013) (0)
HLA Genetic Risk Burden in Multiple Sclerosis-Reply. (2016) (0)
Progress report on the Annals (2009) (0)
OR36 Defining KIR and HLA class I alleles at highest resolution using next generation sequencing (2016) (0)
Whole genome sequences of 2 octogenarians with sustained cognitive abilities Neurobiology of Aging (2015) (0)
Additional file 4: of Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients (2018) (0)
S.110. Tob1 Deficient Mice Experience Early EAE Onset and Present Immunological Abnormalities (2009) (0)
Expression of the cytokine rantes in multiple sclerosis lesions (1994) (0)
Polymorphism in MS (1992) (0)
Rapid Publication Detection of a Protein-Acetaldehyde Adduct in the Liver of Rats Fed Alcohol Chronically (2003) (0)
Immunogenetics in the Holy Land. (2010) (0)
A Predictive Autoantibody Signature in Multiple Sclerosis (2023) (0)
Opposing T cell responses in experimental autoimmune encephalomyelitis (2019) (0)
The use of the polymerase chain reaction to analyze HLA class II sequence polymorphism and genetic susceptibility to myasthenia gravis (1988) (0)
Contribution Variation Within DNA Repair Pathway Genes and Risk of Multiple Sclerosis (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jorge R. Oksenberg?

Jorge R. Oksenberg is affiliated with the following schools:

Jorge R. Oksenberg's Academic­Influence.com Rankings

Jorge R. Oksenberg's Degrees

Why Is Jorge R. Oksenberg Influential?

Jorge R. Oksenberg's Published Works

Published Works

What Schools Are Affiliated With Jorge R. Oksenberg?

Jorge R. Oksenberg's AcademicInfluence.com Rankings